Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome

Clinical trial NCT07691125 · RECRUITING

Trial details

NCT number: NCT07691125
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Short Bowel Syndrome (SBS) in Adults

Start date: 2024-07-31
Primary completion: 2027-04-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.